ACRESTA
Acresta is a global software, technology and services provider with headquarters in Sydney, Australia and offices in Melbourne, Auckland, Singapore, the Philippines and Vietnam delivering innovative business software solutions to meet the needs of today’s enterprises and the environment in which they operate. They are proud to be an industry leader in the provision of customised, agile environmental software and mobile solution platforms.
ACRESTA
Industry:
Information Technology Software
Founded:
2009-01-01
Address:
Sydney, New South Wales, Australia
Country:
Australia
Website Url:
http://www.acresta.com
Total Employee:
11+
Status:
Closed
Contact:
+61 2 8208 3366
Technology used in webpage:
Amazon Nginx YouTube Apple Mobile Web App Capable Common Name Invalid ASP.NET IIS CloudFront IIS 10 Apple Mobile Web App Status Bar Style
Similar Organizations
Cloud Seven
Cloud Seven is an ICT firm that deals in Enterprise Mobility and innovation.
Crescent Info Soft
Crescent Info Soft is an innovative Business Solutions provider and a thought leader in Enterprise Mobility, Enterprise Integration.
Express Mobile
Express Mobile is a technology company that specializes in developing enterprise mobility solutions.
Newest Events participated
Participated in Gartner Symposium/ITxpo Gold Coast 2016
on 2016-10-24 as exhibitor
Official Site Inspections
http://www.acresta.com
- Host name: ec2-54-252-131-106.ap-southeast-2.compute.amazonaws.com
- IP address: 54.252.131.106
- Location: Sydney Australia
- Latitude: -33.8591
- Longitude: 151.2002
- Timezone: Australia/Sydney
- Postal: 2000
More informations about "Acresta"
Alcresta - Crunchbase Company Profile & Funding
Alcresta’s research-based approach is innovative, proprietary and driven by the unmet nutritional needs of those people with compromised health. Alcresta’s …See details»
Alcresta Therapeutics - LinkedIn
Alcresta Therapeutics is dedicated to developing and commercializing novel, enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders …See details»
Linden Capital Partners Acquires Alcresta Therapeutics, Inc.
Chicago, IL and Waltham, MA (March 12, 2024) – Linden Capital Partners ("Linden"), a Chicago-based private equity firm focused exclusively on the healthcare industry, announced today the …See details»
Linden Invests in Alcresta Therapeutics
Mar 12, 2024 We have been impressed with the organization and team that Daniel has built and are excited to partner with Alcresta on this next phase of growth.” Linden’s Ernest Waaser and …See details»
Contact | Alcresta Therapeutics
For more information about Alcresta Therapeutics, please contact us at: Alcresta Therapeutics, Inc. 130 Turner Street Building 3, Suite 200 Waltham, MA 02453 USA Email: [email protected] …See details»
Acresta - Crunchbase Company Profile & Funding
Acresta is a global software, technology and services provider with headquarters in Sydney, Australia and offices in Melbourne, Auckland, Singapore, the Philippines and Vietnam delivering innovative business software solutions to …See details»
ALCRESTA THERAPEUTICS ANNOUNCES EXPANSION OF …
Mar 3, 2025 Since 2020, Mr. Weiner has led the Alcresta Commercial Organization through a period of rapid growth, managing diverse areas including commercial strategy, patient access …See details»
Alcresta Therapeutics - Products, Competitors, Financials, …
Jason Weiner, formerly Chief Commercial Officer at Alcresta, has taken on the new role of Chief Strategy and Business Development Officer. Since 2020, Mr. Weiner has led the Alcresta …See details»
Linden Capital Partners Acquires Alcresta Therapeutics
Mar 12, 2024 Alcresta Therapeutics is a specialty pharmaceutical company focusing on discovering and developing a new generation of enzyme-based products that improve …See details»
Daniel Orlando - CEO at Alcresta Therapeutics | The Org
Daniel Orlando is the Chief Executive Officer of Alcresta Therapeutics. He joins the team with more than 18 years of executive management and corporate development experience leading …See details»
Alcresta Therapeutics, Inc. (Alcresta Therapeutics, Inc.) - 药物管线_ …
了解Alcresta Therapeutics, Inc. (Alcresta Therapeutics, Inc.)公司的药物管线，治疗领域，技术平台，以及它的6项临床试验, 7篇新闻和2篇文献，疾病领域:内分泌与代谢疾病，技术平台:酶， …See details»
Alcresta Announces Board Appointments, Strengthening Team as …
NEWTON, Mass. – June 4, 2013 – Alcresta™, a science-driven company developing innovative enzyme-based nutritional products for adults, infants, and patients battling acute... | NEWTON, …See details»
Alcresta Therapeutics Announces Preclinical Data Showing ALC …
Mar 16, 2023 Alcresta Therapeutics, Inc. is backed by top-tier investors: Athyrium Capital Management, Bessemer Venture Partners, HealthQuest Capital, and Frazier Healthcare …See details»
Latest! Alcresta Therapeutics Announces Expansion Of Leadership …
Mar 3, 2025 Since 2020, Mr. Weiner has led the Alcresta Commercial Organization through a period. of rapid growth, managing diverse areas including commercial strategy, patient access …See details»
| Alcresta Therapeutics
Careers at Alcresta Therapeutics Return to all open positions If you’re interested in joining our team or would like to learn more, please contact [email protected]See details»
Alcresta Therapeutics Announces Publication of Cystic Fibrosis ...
Jul 25, 2023 Alcresta's RELiZORB ® product is the only inline enzyme cartridge on the market. RELiZORB is a first-of-its-kind digestive enzyme cartridge designed to mimic the function of …See details»
Alcresta Therapeutics Announces FDA Clearance for the Next …
Dec 21, 2023 Alcresta Therapeutics, Inc. is dedicated to developing and commercializing novel, enzyme-based products designed to address challenges faced by patients living with …See details»
Science | Alcresta Therapeutics
Alcresta’s proprietary enzyme immobilization technology contains iLipase, the digestive enzyme lipase attached to polymeric microbead carriers, and is stored within a device that easily …See details»
Alcresta Therapeutics | Enzyme products designed for enteral …
Alcresta Therapeutics, Inc. is dedicated to developing and commercializing novel, enzyme-based products designed to address challenges faced by patients living with gastrointestinal …See details»
Products | Alcresta Therapeutics
Enzyme products designed for enteral nutrition. Alcresta Therapeutics pipeline The Next-Generation RELiZORB ® was FDA-cleared in December 2023. The cleared device expands …See details»